Existing differences between available lists of FODMAP containing foods

Martín, Ismael San Mauro; Vilar, Elena Garicano; Oliva, Sara López; Rojo, Sara Sanz

doi:10.17235/reed.2022.8463/2021

Cited by 5 publications

(3 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In 2017, McMeans et al found discrepancies among three commonly used U.S.-based low FODMAP food lists, with an overlap of less than 50% in listed foods [154]. Martin et al more recently reported that 22.6% of the 204 foods listed varied in classification across the 10 studies included [155]. Although the low FODMAP diet has demonstrated efficacy in individuals with IBS, particularly in the short term, the optimal threshold for achieving a total reduction in FODMAPs is yet to be determined.…”

Section: Defining the Low And High Fodmap Content Of Foodmentioning

confidence: 99%

The Role of the FODMAP Diet in IBS

Bertin,

Zanconato,

Crepaldi

et al. 2024

Nutrients

View full text Add to dashboard Cite

The low FODMAP (fermentable oligosaccharide, disaccharide, monosaccharide, and polyol) diet is a beneficial therapeutic approach for patients with irritable bowel syndrome (IBS). However, how the low FODMAP diet works is still not completely understood. These mechanisms encompass not only traditionally known factors such as luminal distension induced by gas and water but also recent evidence on the role of FOMAPs in the modulation of visceral hypersensitivity, increases in intestinal permeability, the induction of microbiota changes, and the production of short-chain fatty acids (SCFAs), as well as metabolomics and alterations in motility. Although most of the supporting evidence is of low quality, recent trials have confirmed its effectiveness, even though the majority of the evidence pertains only to the restriction phase and its effectiveness in relieving abdominal bloating and pain. This review examines potential pathophysiological mechanisms and provides an overview of the existing evidence on the effectiveness of the low FODMAP diet across various IBS subtypes. Key considerations for its use include the challenges and disadvantages associated with its practical implementation, including the need for professional guidance, variations in individual responses, concerns related to microbiota, nutritional deficiencies, the development of constipation, the necessity of excluding an eating disorder before commencing the diet, and the scarcity of long-term data. Despite its recognized efficacy in symptom management, acknowledging these limitations becomes imperative for a nuanced comprehension of the role of a low FODMAP diet in managing IBS. By investigating its potential mechanisms and evidence across IBS subtypes and addressing emerging modulations alongside limitations, this review aims to serve as a valuable resource for healthcare practitioners, researchers, and patients navigating the intricate landscape of IBS.

show abstract

Section: Defining the Low And High Fodmap Content Of Foodmentioning

confidence: 99%

The Role of the FODMAP Diet in IBS

Bertin,

Zanconato,

Crepaldi

et al. 2024

Nutrients

View full text Add to dashboard Cite

show abstract

“…Low‐FODMAP diet decreases total bacteria abundance, such as decreasing Bifidobacteria , Ruminococcus gnavus , Clostridium , F. prausnitzii , and Akkermansia . Low‐FODMAP diet has been used to treat inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS; Guagnozzi et al, 2012 ; Martín et al, 2022 ; Mazzawi et al, 2013 ; Nanayakkara et al, 2016 ; Ostgaard et al, 2012 ; Rinninella, Cintoni, et al, 2019 ).…”

Section: Food/food Components and Dietary Supplements May Promote Gut...mentioning

confidence: 99%

Food, gut barrier dysfunction, and related diseases: A new target for future individualized disease prevention and management

Liang

Saunders

Sanossian

2023

Food Science & Nutrition

View full text Add to dashboard Cite

Dysfunction of gut barrier is known as “leaky gut” or increased intestinal permeability. Numerous recent scientific evidences showed the association between gut dysfunction and multiple gastrointestinal tract (GI) and non‐GI diseases. Research also demonstrated that food plays a crucial role to cause or remedy gut dysfunction related to diseases. We reviewed recent articles from electronic databases, mainly PubMed. The data were based on animal models, cell models, and human research in vivo and in vitro models. In this comprehensive review, our aim focused on the relationship between dietary factors, intestinal permeability dysfunction, and related diseases. This review synthesizes currently available literature and is discussed in three parts: (a) the mechanism of gut barrier and function, (b) food and dietary supplements that may promote gut health, and food or medication that may alter gut function, and (c) a table that organizes the synthesized information by general mechanisms for diseases related to leaky gut/intestinal permeability and associated dietary influences. With future research, dietary intervention could be a new target for individualized disease prevention and management.

show abstract

“…FODMAP occurs naturally in various foods that contain oligosaccharides and disaccharides (e.g., dairy products), such as fructans (e.g., garlic and onion), galacto-oligosaccharides (e.g., vegetables), and monosaccharides (e.g., honey), but also polyols used as sweeteners (e.g., sorbitol, mannitol, and xylitol). The amount of FODMAP is dependent on the species and the maturity of the product [ 55 , 56 , 57 , 58 ].…”

Section: Low-fodmap Dietmentioning

confidence: 99%

Effects of a Low-FODMAP Diet on Irritable Bowel Syndrome in Both Children and Adults—A Narrative Review

Morariu,

Avasilcai,

Vieriu

et al. 2023

Nutrients

View full text Add to dashboard Cite

Irritable bowel syndrome is a typical gastrointestinal disease that causes bloating, flatulence, abdominal pain, diarrhoea, constipation, or alteration of the last two in adults and children. A diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) is one of the potential treatment strategies to reduce abdominal symptoms and increase the quality of life. The present narrative review aims to present a general overview of current studies that have evaluated the efficacy of a low-FODMAP diet against other diets in gastrointestinal symptoms, nutrient intake in adults and children, and lifestyle quality. The research was performed using seven searchable databases, which included the Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Database of Systematic Reviews (CDSR), Excerpta Medica Database (EMBASE), Medline, PubMed, Scopus, and Web of Science, up to March 2023. In conclusion, there is significant evidence that the follow-up of a low-FODMAP diet might be a feasible first-line therapeutic strategy to reduce stomach discomfort, pain, bloating, and quality of life for patients with irritable bowel syndrome.

show abstract

Existing differences between available lists of FODMAP containing foods

Cited by 5 publications

References 18 publications

The Role of the FODMAP Diet in IBS

The Role of the FODMAP Diet in IBS

Food, gut barrier dysfunction, and related diseases: A new target for future individualized disease prevention and management

Effects of a Low-FODMAP Diet on Irritable Bowel Syndrome in Both Children and Adults—A Narrative Review

Contact Info

Product

Resources

About